Acorda Therapeutics
Acorda Therapeutics is a biotechnology company that develops therapies for neurological disorders. The company is headquartered in Ardsley, New York.
History[edit]
Acorda Therapeutics was founded in 1995 by Ron Cohen, M.D., with the mission to develop therapies that restore function and improve the lives of people with neurological disorders. The company initially focused on developing treatments for spinal cord injury and later expanded its research to include other neurological conditions such as multiple sclerosis (MS) and Parkinson's disease.
Products[edit]
Acorda Therapeutics is known for developing several key products in the field of neurology:
- Ampyra (dalfampridine): A medication approved by the Food and Drug Administration (FDA) to improve walking in patients with multiple sclerosis. It works by blocking potassium channels on the surface of nerve cells, which helps improve nerve signal conduction.
- Inbrija (levodopa inhalation powder): An inhaled form of levodopa used to treat "off" episodes in patients with Parkinson's disease who are already taking a carbidopa/levodopa regimen. It provides rapid relief from symptoms by delivering levodopa directly to the bloodstream through the lungs.
Research and Development[edit]
Acorda Therapeutics invests heavily in research and development to discover new treatments for neurological disorders. The company's R&D efforts focus on innovative drug delivery systems and novel therapeutic targets. Acorda collaborates with academic institutions and other biotechnology companies to advance its research pipeline.
Corporate Structure[edit]
Acorda Therapeutics operates as a publicly traded company on the NASDAQ stock exchange under the ticker symbol "ACOR." The company is governed by a board of directors and led by a team of executives with extensive experience in the biotechnology and pharmaceutical industries.
Community Involvement[edit]
Acorda Therapeutics is committed to supporting the neurological community through various initiatives. The company sponsors educational programs, patient advocacy groups, and research foundations to raise awareness and improve the quality of life for individuals with neurological disorders.
Related pages[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
